Cytoprotective and enhanced anti-inflammatory activities of liposomal piroxicam formulation in lipopolysaccharide-stimulated RAW 264.7 macrophages

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 1245-1255

  Chiong, Hoe Siong ^a   Yong, Yoke Keong ^a   Ahmad, Zuraini ^a   Sulaiman, Mohd Roslan ^a   Zakaria, Zainul Amiruddin ^a   Yuen, Kah Hay ^b   Nazrul Hakim, Muhammad ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Cytokines; Interleukin 1 ; Liposomes; Nitric oxide; Piroxicam; Prostaglandin E2

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; LIPOSOME; NITRIC OXIDE; PIROXICAM; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; ENCAPSULATION; IN VITRO STUDY; MACROPHAGE; NONHUMAN;

CYTOKINES; INTERLEUKIN-1Β; LIPOSOMES; NITRIC OXIDE; PIROXICAM; PROSTAGLANDIN E2;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CRYOPROTECTIVE AGENTS; CYTOKINES; DINOPROSTONE; DRUG DELIVERY SYSTEMS; LIPOPOLYSACCHARIDES; LIPOSOMES; MACROPHAGES; MICE; NITRIC OXIDE; PIROXICAM;

EID: 84875493753     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S42801     Document Type: Article

References (37)

1. Gayathri B, Manjula N, Vinaykumar KS, Lakshmi BS, Balakrishnan A. Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNFalpha, IL-1beta, NO and MAP kinases. Int Immunopharmacol. 2007;7(4):473-482.
2. Kim HG, Shrestha B, Lim SY, et al. Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-kappaB through Akt and p38 inhibition in RAW 264.7 macrophage cells. Eur J Pharmacol. 2006;545(2-3):192-199.
3. Hsueh R, Roach T. Passage Procedure for RAW 264.7 cells. AfCS Procedure Protocol PP00000159. Dallas: Alliance for Cellular Signaling; 2003. Available from: http://www.signaling-gateway.org/data/cgi-bin/ProtocolFile.cgi/afcs_PP00000159.pdf?pid=PP00000159. Accessed February 13, 2013.
4. Orlicek SL, Meals E, English BK. Differential effects of tyrosine kinase inhibitors on tumor necrosis factor and nitric oxide production by murine macrophages. J Infect Dis. 1996;174(3):638-642.
5. Harasstani OA, Moin S, Tham CL, et al. Flavonoid combinations cause synergistic inhibition of proinflammatory mediator secretion from lipopolysaccharide-induced RAW 264.7 cells. Inflamm Res. 2010;59(9):711-721.
6. Kim YK, Kang HJ, Lee KT, Choi JG, Chung SH. Anti-inflammation activity of Actinidia polygama. Arch Pharm Res. 2003;26(12):1061-1066.
7. Reddy MC, Subhashini J, Mahipal SV, et al. C-Phycocyanin, a selective cyclooxygenase-2 inhibitor, induces apoptosis in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biochem Biophys Res Commun. 2003;304(2):385-392.
8. Kim ID, Ha BJ. Paeoniflorin protects RAW 264.7 macrophages from LPS-induced cytotoxicity and genotoxicity. Toxicol In Vitro. 2009;23(6):1014-1019.
9. Jalava PI, Salonen RO, Pennanen AS, et al. Effects of solubility of urban air fine and coarse particles on cytotoxic and inflammatory responses in RAW 264.7 macrophage cell line. Toxicol Appl Pharm. 2008;229(2):146-160.
10. Israf DA, Tham CL, Syahida A, et al. Atrovirinone inhibits proinflammatory mediator synthesis through disruption of NF-kappaB nuclear translocation and MAPK phosphorylation in the murine monocytic macrophage RAW 264.7. Phytomedicine. 2010;17(10):732-739.
11. Verdina A, Cardillo I, Nebbioso A, et al. Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability. J Transl Med. 2008;6:27.
12. Vasudevan DM, Sreekumari S, Vaidyanathan K. Chemical basis of life. In: Textbook of Biochemistry for Medical Students, 6th ed. New Delhi: Jaypee Brothers Medical; 2011:1-82.
13. Lopes LB, Scarpa MV, Pereira NL, Oliveira LC, Oliveira AG. Interaction of sodium diclofenac with freeze-dried soya phosphatidylcholine and unilamellar liposomes. Revista Brasileira de Ciências Farmacêuticas. 2006;42(4):497-504.
14. Chen H, Khemtong C, Yang X, Chang X, Gao J. Nanonization strategies for poorly water-soluble drugs. Drug Discov Today. 2011;16(7-8):354-360.
15. Fricker G, Kromp T, Wendel A, et al. Phospholipids and lipid-based formulations in oral drug delivery. Pharm Res. 2010;27(8):1469-1486.
16. Chakraborty S, Shukla D, Mishra B, Singh S. Lipid - an emerging platform for oral delivery of drugs with poor bioavailability. Eur J Pharm Biopharm. 2009;73(1):1-15.
17. Hussein H, Hussain H, Salbiah MS, Muhaini O, Low YL, Beh PK. Use of drugs for rheumatological and bone disorders. In: Faridah AM, Sivasampu S, Lian LM, Hazimah H, Kok LC, Chinniah RJ, editors. Malaysian Statistics on Medicines 2007. Kuala Lumpur: Ministry of Health Malaysia; 2010:109-116.
18. Mosby. Piroxicam. In: 2007 Mosby's Drug Consult, 17th ed. St Louis, MO: Elsevier; 2006:II2336-II2338.
19. Leikin JB, Paloucek FP. Piroxicam. In: Poisoning and Toxicology Handbook, 4th ed. Boca Raton, FL: CRC Press; 2008:553-554.
20. Chiong HS, Nazrul Hakim M, Sulaiman MR, et al. Development and characterisation study of liposomes-encapsulated piroxicam. Int J Drug Deliv. 2011;3(1):64-73.
21. Chiong HS, Somchit MN, Azhar Y, Ong SG, Yuen KH. Preparation and in-vitro evaluation of blank and piroxicam-loaded liposomes. J Ind Tech. 2010;19(1):17-30.
22. Israf DA, Khaizurin TA, Syahida A, Lajis NH, Khozirah S. Cardamonin inhibits COX and iNOS expression via inhibition of p65 NF-kappaB nuclear translocation and Ikappa-B phosphorylation in RAW 264.7 macrophage cells. Mol Immunol. 2007;44(5):673-679.
23. Park KS, Kim BH, Chang IM. Inhibitory Potencies of Several Iridoids on Cyclooxygenase-1, Cyclooxygnase-2 Enzymes Activities, Tumor Necrosis factor-α and Nitric Oxide Production In Vitro. Evid Based Complement Alternat Med. 2010;7(1):41-45.
24. Chou TC, Fu E, Shen EC. Chitosan inhibits prostaglandin E2 formation and cyclooxygenase-2 induction in lipopolysaccharide-treated RAW 264.7 macrophages. Biochem Biophys Res Commun. 2003;308(2):403-407.
25. Sun LK, Wahl P, Bilic G, Wüthrich RP. CD44-mediated cyclooxygenase-2 expression and thromboxane A2 production in RAW 264.7 macrophages. Inflamm Res. 2001;50(10):496-499.
26. Genlantis. A Highly Efficient Method of Transfecting RAW 264.7 Cells. San Diego, CA: Genlantis; 2009.
27. Lee J, Kim KA, Jeong S, et al. Anti-inflammatory, anti-nociceptive, and anti-psychiatric effects by the rhizomes of Alpinia officinarum on complete Freund's adjuvant-induced arthritis in rats. J Ethnopharmacol. 2009;126(2):258-264.
28. Kumar-Roiné S, Matsui M, Reybier K, et al. Ability of certain plant extracts traditionally used to treat ciguatera fish poisoning to inhibit nitric oxide production in RAW 264.7 macrophages. J Ethnopharmacol. 2009;123(3):369-377.
29. Yen GC, Duh PD, Huang DW, Hsu CL, Fu TY. Protective effect of pine (Pinus morrisonicola Hay.) needle on LDL oxidation and its anti-inflammatory action by modulation of iNOS and COX-2 expression in LPS-stimulated RAW 264.7 macrophages. Food Chem Toxicol. 2008;46(1):175-185.
30. Garcia X, Stein F. Nitric oxide. Semin Pediatr Infect Dis. 2006;17(2):55-57.
31. Ahn EK, Jeon HJ, Lim EJ, Jung HJ, Park EH. Anti-inflammatory and anti-angiogenic activities of Gastrodia elata Blume. J Ethnopharmacol. 2007;110(3):476-482.
32. Kim KW, Ha KT, Park CS, et al. Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 macrophages. Vascul Pharmacol. 2007;47(2-3):99-107.
33. Lee MH, Lee JM, Jun SH, et al. The anti-inflammatory effects of Pyrolae herba extract through the inhibition of the expression of inducible nitric oxide synthase (iNOS) and NO production. J Ethnopharmacol. 2007;112(1):49-54.
34. Sharma JN, Al-Omran A, Parvathy SS. Role of nitric oxide in inflammatory diseases. Inflammopharmacology. 2007;15(6):252-259.
35. Loram LC, Fuller A, Fick LG, Cartmell T, Poole S, Mitchell D. Cytokine profiles during carrageenan-induced inflammatory hyperalgesia in rat muscle and hind paw. J Pain. 2007;8(2):127-136.
36. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010;10(3):170-181.
37. Li L, Rossoni G, Sparatore A, Lee LC, Del Soldato P, Moore PK. Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic Biol Med. 2007;42(5):706-719.